Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning (Allergen) - Brewer's Yeast sold at New Life Mills Town & Country recalled due to undeclared peanut


For more information: https://bit.ly/2DHs7xU

OTTAWA, Feb. 15, 2019 /CNW/ - The food recall warning issued earlier today has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

New Life Mills Town & Country is recalling repackaged Brewer's Yeast from the marketplace because it contains peanut which is not declared on the label. People with an allergy to peanut should not consume the recalled product described below. 

The following product has been sold at New Life Mills Town & Country #7 Bruce Road 22 RR#3 Hanover, Ontario.

Recalled product

 

Brand

Product

Size

UPC

Codes

None

Brewer's Yeast

1 lb

none

All units sold from February 22, 2018 up to and including February 15, 2019.

 

What you should do

Check to see if you have recalled product in your home. Recalled product should be thrown out or returned to the store where it was purchased.

If you have an allergy to peanut do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions for the Brewer's Yeast sold at New Life Mills Town & Country. However, there have been reported reactions associated with other recently recalled Brewer's Yeast products.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: